Total Voting Rights

Report this content

14 January 2019 

Faroe Petroleum plc 

("Faroe Petroleum" or the "Company") 

Issue of Equity and Total Voting Rights 

  

Further to its announcement on 11 January 2018, the Company confirms that it has applied to the London Stock Exchange for 23,052,775 new Ordinary Shares "the New Ordinary Shares") to be admitted to trading on AIM ("Admission"). Admission is expected on 15 January 2019. The New Ordinary Shares will, rank pari passu in all respects with the existing issued ordinary shares. 

Following the issue of 23,052,775 New Ordinary Shares the Company's enlarged issued share capital will be 395,942,468 ordinary shares. The Company does not hold any ordinary shares in treasury and therefore the total number of voting rights in the Company is 395,942,468.
Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules. 

  

- Ends - 

For further information please contact: 

Faroe Petroleum plcGraham Stewart, CEO Tel: +44 1224 650 920
Stifel Nicolaus Europe Limited Callum Stewart /Nicholas Rhodes / Ashton Clanfield Tel: +44 207 710 7600
BMO Capital MarketsTom Rider / Jeremy Low/Tom Hughes Tel: +44 207 236 1010
FTI ConsultingBen Brewerton/ Emerson Clarke Tel: +44 207 831  3113

The information contained within this announcement is considered to be inside information prior to its release, as defined in Article 7 of the Market Abuse Regulation No. 596/2014, and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Documents & Links